Retroperitoneal Fibrosis: Evaluation by Ultrasonography and Color Doppler Imaging

Erden, A.; Aytaç, Suat; Cumhur, Turhan; Yurdakul, Mehmet; Çalikoğlu, Ümit

doi:10.1159/000282763

Cited by 4 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Doppler interrogation is often useful in identifying the aorta and IVC within the soft tissue mass. It is not possible to distinguish between idiopathic and malignant retroperitoneal fibrosis by Doppler evaluation alone 34 …”

Section: Retrograde Pyelography (Fig 2)mentioning

confidence: 99%

Imaging and intervention of retroperitoneal fibrosis

Geoghegan

Byrne

Benfayed

et al. 2007

Australasian Radiology

View full text Add to dashboard Cite

Retroperitoneal fibrosis is a rare condition characterized by the development of fibrous plaques in the retroperitoneal space. The fibrous plaques characteristically arise distal to the bifurcation of the abdominal aorta and progress to encase the iliac vessels distally and are defined by the associated encasement of one or both ureters. Imaging plays an important role in not only establishing the diagnosis, but also in monitoring disease progression. Historically, the radiological diagnosis was made predominantly by intravenous urography and retrograde pyelography. More recently, advances in cross-sectional imaging with ultrasound and contrast-enhanced CT have allowed for a more precise diagnosis as well as helping to accurately define the extent of the disease. At our institution, we have found ultra-fast MRI to also play a useful role in establishing the diagnosis. In particular, magnetic resonance urography using HASTE (half Fourier-acquired single shot turbo spin-echo) sequences allow a safe alternative to intravenous urography, particularly in patients with poor renal function. The purpose of this article is to describe the role of the various imaging methods available to the radiologist and to emphasize the important role that the interventional radiologist now plays, not only in obtaining tissue for diagnosis, but also in providing treatment of the disease by percutaneous nephrostomy drainage and subsequent stent placement in select cases.

show abstract